European anti-counterfeit scheme moves on amid industry concerns
This article was originally published in Scrip
The Council of Europe's department for the quality of medicines (EDQM) is working on a "track-and-trace" project that it says will be able to link up national traceability systems in a Europe-wide platform to help prevent counterfeit medicines entering the supply chain. However, the European pharmaceutical industry association and other players have expressed concern over the costs and practicalities of implementing such a system.
You may also be interested in...
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.
With product shortages made worse by the pandemic, companies in the UK are being asked to use a new system for notifying potential supply disruptions and any plans to discontinue specific medicines.
Two new projects have begun, one on standardizing the assessment of immune responses in individuals vaccinated in clinical trials, the other to improve understanding of potential immunity in patients who have been infected with SARS-CoV-2.